215 related articles for article (PubMed ID: 11677199)
1. Inflammatory bowel disease is not associated with an increased risk of lymphoma.
Lewis JD; Bilker WB; Brensinger C; Deren JJ; Vaughn DJ; Strom BL
Gastroenterology; 2001 Nov; 121(5):1080-7. PubMed ID: 11677199
[TBL] [Abstract][Full Text] [Related]
2. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
[TBL] [Abstract][Full Text] [Related]
3. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
4. [Inflammatory bowel diseases and lymphoma].
Karoui S; Boubaker J; Filali A
Tunis Med; 2004 Feb; 82(2):185-9. PubMed ID: 15185593
[TBL] [Abstract][Full Text] [Related]
5. Risk of lymphoma in inflammatory bowel disease.
Loftus EV; Tremaine WJ; Habermann TM; Harmsen WS; Zinsmeister AR; Sandborn WJ
Am J Gastroenterol; 2000 Sep; 95(9):2308-12. PubMed ID: 11007233
[TBL] [Abstract][Full Text] [Related]
6. Increased risk for demyelinating diseases in patients with inflammatory bowel disease.
Gupta G; Gelfand JM; Lewis JD
Gastroenterology; 2005 Sep; 129(3):819-26. PubMed ID: 16143121
[TBL] [Abstract][Full Text] [Related]
7. Risk for active tuberculosis in inflammatory bowel disease patients.
Aberra FN; Stettler N; Brensinger C; Lichtenstein GR; Lewis JD
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1070-5. PubMed ID: 17627901
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease.
Gupta G; Lautenbach E; Lewis JD
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1483-90. PubMed ID: 17162240
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk in patients with inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Kliewer E; Wajda A
Cancer; 2001 Feb; 91(4):854-62. PubMed ID: 11241255
[TBL] [Abstract][Full Text] [Related]
10. Risk of haematopoietic cancer in patients with inflammatory bowel disease.
Askling J; Brandt L; Lapidus A; Karlén P; Björkholm M; Löfberg R; Ekbom A
Gut; 2005 May; 54(5):617-22. PubMed ID: 15831904
[TBL] [Abstract][Full Text] [Related]
11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease.
Sultan K; Korelitz BI; Present D; Katz S; Sunday S; Shapira I
Inflamm Bowel Dis; 2012 Oct; 18(10):1855-8. PubMed ID: 22241664
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study.
Huang WS; Tseng CH; Chen PC; Tsai CH; Lin CL; Sung FC; Kao CH
Eur J Intern Med; 2014 Jul; 25(6):561-5. PubMed ID: 24906568
[TBL] [Abstract][Full Text] [Related]
14. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE
Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
[TBL] [Abstract][Full Text] [Related]
15. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
[TBL] [Abstract][Full Text] [Related]
16. Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?
Bebb JR; Logan RP
Aliment Pharmacol Ther; 2001 Dec; 15(12):1843-9. PubMed ID: 11736713
[TBL] [Abstract][Full Text] [Related]
17. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
Khan N; Abbas AM; Lichtenstein GR; Loftus EV; Bazzano LA
Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.
Kandiel A; Fraser AG; Korelitz BI; Brensinger C; Lewis JD
Gut; 2005 Aug; 54(8):1121-5. PubMed ID: 16009685
[TBL] [Abstract][Full Text] [Related]
19. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
Kappelman MD; Horvath-Puho E; Sandler RS; Rubin DT; Ullman TA; Pedersen L; Baron JA; Sørensen HT
Gut; 2011 Jul; 60(7):937-43. PubMed ID: 21339206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
